The Douglas Mental Health University Institute
The McGill University Research Centre for Studies in Aging (MCSA) at the Douglas Mental Health University Institute
The MCSA is investigating causes and treatments of the various types of cognitive decline with age, especially Alzheimer’s disease (AD). The MCSA has played a pioneering role in identifying ApoE4 as increasing the risk for late onset AD, testing symptomatic drugs approved in Canada, and new ones aiming at disease stabilization.
We have a special interest and expertise in early onset (before age 65) dementias. Although Alzheimer’s disease is a common form of dementia in younger people, other causes must be investigated, such as frontotemporal dementia. Furthermore, other neurological diseases or health issues such as stress, anxiety or depression can cause cognitive and behavioral symptoms mimicking dementia.
Our clinic collaborates with other experts at McGill University, using biomarkers such as cerebrospinal fluid examination and neuroimaging (MRI and PET) to evaluate patients with mild cognitive impairment and atypical dementias. The PET and MRI technologies combined with our clinical expertise, allow for an early diagnosis and appropriate treatment of the conditions causing cognitive decline. We perform lumbar punctures on site at the McGill University Research Centre for Studies in Aging, and neuroimaging studies (PET scans) at the Montreal Neurological Institute.
Neurologist members:
Dr. Maiya Geddes
Dr. Pedro Rosa-Neto, Director of the MCSA
Dr. Paolo Vitali
For appointments contact:
Mrs. Tamar Tatigian
tamar.tatigian [at] mcgill.ca
Tel: 514 766 2010